An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations

Clinical trial NCT01646125 · TERMINATED

Trial details

NCT number

NCT01646125

Sponsor

Novartis Pharmaceuticals

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2012-11-23

Primary completion

2015-11-04

Enrollment

59

View on ClinicalTrials.gov